NCT06474000

Brief Summary

The aim of the study is to compare pain and stress levels in the early neonatal period in newborns with and without oxytocin induction. The research was conducted in a case-control study design. The population of the study consisted of participants who gave birth vaginally (with or without oxytocin induction). The sample number of the study was calculated with the G\*Power 3.1.9.2 program, taking into account the mean and standard deviation values of the NIPS score in Cetinkaya et al., (2020). Effect size: 0.666, α= 0.05, power: 0.95, oxytocin induction group: 60, non-oxytocin induction group: 60. Anticipating possible data loss, 164 participants and their newborns were included, 85 in the oxytocin induction group and 79 in the non-oxytocin induction group. was included. The data of the study were collected using the Pregnant Information Form, Neonatal Follow-up Form and Newborn Pain and Stress Assessment Scale (ALPS-Neo). The research data were analyzed in SPSS 29.0 (IBM) program.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
164

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 20, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 10, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

June 19, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 25, 2024

Completed
Last Updated

June 25, 2024

Status Verified

June 1, 2024

Enrollment Period

11 months

First QC Date

June 19, 2024

Last Update Submit

June 19, 2024

Conditions

Keywords

OxytocinLaborNewbornPainStressInduced

Outcome Measures

Primary Outcomes (3)

  • Filling out the ALPS-Neo form before the newborn drying procedure.

    ALPS-Neo form was completed before the newborn drying procedure.

    In the first minute after birth.

  • Filling in the ALPS-Neo form during the newborn drying process.

    ALPS-Neo form was filled out during the newborn drying process.

    At 5 minutes after birth.

  • Filling out the ALPS-Neo form after the newborn drying procedure.

    ALPS-Neo form was completed after the newborn drying procedure.

    At the 5th minute after drying.

Secondary Outcomes (3)

  • Completion of the ALPS-Neo form before the first injection procedure in the newborn.

    At 15 minutes after birth.

  • Completion of the ALPS-Neo form during the first injection procedure in the newborn.

    At 20 minutes after birth.

  • Completion of the ALPS-Neo form after the first injection procedure in the newborn.

    At 5 minutes after the first injection.

Other Outcomes (3)

  • Filling out the ALPS-Neo form before the newborn blood glucose measurement procedure.

    At 30 minutes after birth.

  • Filling in the ALPS-Neo form during the neonatal blood glucose measurement procedure.

    At 35 minutes after birth.

  • Filling out the ALPS-Neo form after the newborn blood glucose measurement procedure.

    At the 5th minute after blood glucose measurement.

Study Arms (2)

Oxytocin induction group

ACTIVE COMPARATOR

Participants in the oxytocin induction group received oxytocin induction during labour. The ALPS-Neo form was completed between 1-40 minutes after delivery, based on observation before, during and after the drying process, the first injection process and the blood glucose measurement procedures.

Behavioral: Oxytocin induction group

Control group

ACTIVE COMPARATOR

Participants in the control group did not receive oxytocin induction during labour. The ALPS-Neo form was completed between 1-40 minutes after delivery, based on observation before, during and after the drying process, the first injection procedure and the blood glucose measurement procedures.

Behavioral: Control group

Interventions

Participants in the oxytocin induction group filled out the "Information Form" at the time of application to the delivery room. Routine care was performed. ALPS-Neo was filled before, during and at 5 minutes after the drying of the newborn within 1-40 minutes after birth. ALPS-Neo was filled before, during and 5 minutes after the first injection. ALPS-Neo was filled before, during and 5 minutes after the blood glucose measurement procedure.

Oxytocin induction group
Control groupBEHAVIORAL

Participants in the control group filled in the "Information Form" when they applied to the birth centre. Routine care was performed. ALPS-Neo was filled before, during and at 5 minutes after the drying of the newborn within 1-40 minutes after birth. ALPS-Neo was filled before, during and 5 minutes after the first injection. ALPS-Neo was filled before, during and 5 minutes after the blood glucose measurement procedure.

Control group

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Pregnant at term,
  • Giving birth vaginally,
  • Birth weight ≥2500gr,
  • Participants with a single and healthy fetus and their newborns

You may not qualify if:

  • Mentally incompetent,
  • Having a high-risk pregnancy,
  • Those with risky newborns

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kocaeli University

Kocaeli, 41380, Turkey (Türkiye)

Location

Related Publications (1)

  • Cetinkaya S, Yavas Celik M, Ozdemir S. Effect of white noise on alleviating the pain of new-born during invasive procedures. J Matern Fetal Neonatal Med. 2022 Apr;35(8):1426-1432. doi: 10.1080/14767058.2020.1755652. Epub 2020 Apr 21.

    PMID: 32316794BACKGROUND

MeSH Terms

Conditions

Pain

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Sena Dilek Aksoy, Ph.D.

    Kocaeli University

    PRINCIPAL INVESTIGATOR
  • Seda Yazici Yel, M.Sc.

    Darica Farabi Training and Research Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 19, 2024

First Posted

June 25, 2024

Study Start

January 20, 2023

Primary Completion

December 10, 2023

Study Completion

December 10, 2023

Last Updated

June 25, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations